A Study to Assess the Effects of Savolitinib on the Pharmacokinetics of Digoxin, Rosuvastatin, Metformin, and Furosemide in Healthy Male Subjects
Clinical trial NCT05768360 · COMPLETED
Trial details
- NCT number
- NCT05768360
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-25
- Primary completion
- 2023-06-24
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.